Editorials

• Risk stratification by magnetic resonance in chronic coronary syndrome

  Jesús Peteiro, Alberto Bouzas-Mosquera

  Rev Esp Cardiol. 2022;75:200-2

• Transradial access. Should we keep turning left?

  Javier Goicolea Ruigómez

  Rev Esp Cardiol. 2022;75:110-1

• The 5W1H in antiplatelet monotherapy after percutaneous coronary intervention: what, who, where, when, why, and how?

  Usman Baber

  Rev Esp Cardiol. 2022;75:115-8

• Clinical impact of variability in blood concentrations of calcineurin inhibitors in heart transplant: a double-edged sword

  Lorena Santulario Verdú, Elena García-Romero, Carles Díez-López

  Rev Esp Cardiol. 2022;75:112-4

• ICD in primary prevention: the ugly duckling of Spain

  Ignacio Fernández Lozano

  Rev Esp Cardiol. 2022;75:2-4

• Acute heart failure. The quintessential cardiac emergency

  Carlos Peña-Gil, Violeta González-Salvado, Jaume Figueras-Bellot

  Rev Esp Cardiol. 2022;75:9-11

• Magnetic resonance-assessed lipoprotein profile. The time has come for its clinical use

  Lluís Masana, Daiana Ibarretxe

  Rev Esp Cardiol. 2022;75:5-8

• (Collaborative) cardiovascular research in Spain: quo vadis?

  Javier Bermejo, Javier Díez, Francisco Fernández-Avilés

  Rev Esp Cardiol. 2021;74:898-900

• Preventing ventricular arrhythmias and sudden cardiac death in adults with repaired tetralogy of Fallot: a never-ending story?

  José María Oliver-Ruiz, Rafael Peinado-Peinado

  Rev Esp Cardiol. 2021;74:905-8

• Novel drug-eluting stents to improve coronary endothelial and microvascular function in STEMI patients?

  Benjamin Beska, Daniell Edward Raharjo, Vijay Kunadian

  Rev Esp Cardiol. 2021;74:1003-5

• Is a picture worth a thousand words in cardiovascular risk assessment?

  Ramón Estruch, Emilio Sacanella

  Rev Esp Cardiol. 2021;74:1006-7

• Heart failure-related skeletal myopathy. Potential involvement of myokines

  Íñigo Latasa Amézqueta, Robinson Ramírez-Vélez, Mikel Izquierdo, Javier Díez

  Rev Esp Cardiol. 2021;74:1008-12

• Importance of nonobstructive atheromatosis in patients with acute myocardial infarction

  Enrique Gutiérrez, Josep Gómez-Lara, Raúl Moreno

  Rev Esp Cardiol. 2021;74:901-4

• Prognosis after an acute myocardial infarction: survivor life expectancy

  Guillermo Aldama, Fernando Rebollal, Pablo Piñón

  Rev Esp Cardiol. 2021;74:820-2

• Further improvements in coronary heart disease mortality in Spain: context, paradoxes, and pathways forward

  Miguel Cainzos-Achirica, Usama Bilal

  Rev Esp Cardiol. 2021;74:823-6

• Primary prevention. The cornerstone to reduce the burden of cardiovascular disease

  Vivencio Barrios, Carlos Escobar, Maciej Banach

  Rev Esp Cardiol. 2021;74:827-8

• miR-16 induces endoplasmic reticulum stress in ischemic dilated cardiomyopathy

  Sandra Sánchez-Esteban, Carlos Zaragoza, Marta Saura

  Rev Esp Cardiol. 2021;74:732-3

• Can we improve the prognosis of postinfarction ventricular septal rupture?

  José A. Barrabés, Irene Buera, Rafael Rodríguez-Lecoq

  Rev Esp Cardiol. 2021;74:737-9

• Cardiovascular disease: still far from being beaten

  Jaume Marrugat, Anna Camps-Vilaró, Helena Tizón-Marcos

  Rev Esp Cardiol. 2021;74:734-6

• Is indexed right ventricular end-diastolic volume a new key for the tricuspid regurgitation puzzle?

  Daniel Perez-Camargo, Ana Paula Tagliari, Maurizio Taramasso

  Rev Esp Cardiol. 2021;74:646-7